Women’s and family health tech startup Maven Clinic announced Monday it has raised $90 million in a Series E funding round led by General Catalyst, raising the company’s valuation to $1.35 billion.
The funding, which brought Maven’s total funding to $300 million, comes at a time when investment into health tech companies has slowed, with patients returning to their doctors’ offices and employers considering scaling back their virtual care benefits amid an economic downturn. Yet the market shift back to pre-Covid levels did not shake the confidence of Maven’s investors, who said they see the need for maternal and family health care only growing in a post-Roe world.
“Regardless of what’s happening in the financial markets, the state of the maternal health crisis in the U.S. is more acute than ever,” said Holly Maloney, the managing director at General Catalyst.“Even when, in theory, employer budgets may be tightening … it’s clear that anyone who already offers something like Maven as a benefit is certainly not going to be going away,” she added.
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect